CN104487567A - 用于收集、洗涤、冷冻保存、回收并且将脂肪抽出物返回给医师进行自体脂肪转移手术的组合物及方法 - Google Patents
用于收集、洗涤、冷冻保存、回收并且将脂肪抽出物返回给医师进行自体脂肪转移手术的组合物及方法 Download PDFInfo
- Publication number
- CN104487567A CN104487567A CN201380039198.8A CN201380039198A CN104487567A CN 104487567 A CN104487567 A CN 104487567A CN 201380039198 A CN201380039198 A CN 201380039198A CN 104487567 A CN104487567 A CN 104487567A
- Authority
- CN
- China
- Prior art keywords
- fatty tissue
- tissue
- solution
- freezen protective
- glycerine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 47
- 238000005406 washing Methods 0.000 title claims abstract description 28
- 238000012546 transfer Methods 0.000 title claims abstract description 11
- 239000000203 mixture Substances 0.000 title description 3
- 210000000577 adipose tissue Anatomy 0.000 claims abstract description 124
- 210000001519 tissue Anatomy 0.000 claims abstract description 24
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 91
- 230000001681 protective effect Effects 0.000 claims description 54
- 239000000243 solution Substances 0.000 claims description 49
- 235000011187 glycerol Nutrition 0.000 claims description 45
- 210000001789 adipocyte Anatomy 0.000 claims description 33
- 239000000523 sample Substances 0.000 claims description 33
- 239000012891 Ringer solution Substances 0.000 claims description 31
- 239000003795 chemical substances by application Substances 0.000 claims description 23
- 239000012472 biological sample Substances 0.000 claims description 21
- 210000004027 cell Anatomy 0.000 claims description 21
- 238000011084 recovery Methods 0.000 claims description 21
- 238000007710 freezing Methods 0.000 claims description 19
- 230000008014 freezing Effects 0.000 claims description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- 238000001816 cooling Methods 0.000 claims description 16
- 238000012360 testing method Methods 0.000 claims description 16
- 229960002424 collagenase Drugs 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 14
- DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 claims description 13
- DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 claims description 13
- 238000003908 quality control method Methods 0.000 claims description 13
- 239000000725 suspension Substances 0.000 claims description 13
- 238000010257 thawing Methods 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 12
- 239000004033 plastic Substances 0.000 claims description 10
- 229920003023 plastic Polymers 0.000 claims description 10
- 102000029816 Collagenase Human genes 0.000 claims description 8
- 108060005980 Collagenase Proteins 0.000 claims description 8
- 230000029087 digestion Effects 0.000 claims description 8
- 238000012545 processing Methods 0.000 claims description 7
- 230000002792 vascular Effects 0.000 claims description 7
- 238000001356 surgical procedure Methods 0.000 claims description 5
- 238000004458 analytical method Methods 0.000 claims description 4
- 230000001413 cellular effect Effects 0.000 claims description 4
- 238000011109 contamination Methods 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 4
- 238000002386 leaching Methods 0.000 claims description 4
- 230000000813 microbial effect Effects 0.000 claims description 4
- 238000005204 segregation Methods 0.000 claims description 4
- 238000009792 diffusion process Methods 0.000 claims description 3
- 239000001963 growth medium Substances 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 230000009466 transformation Effects 0.000 claims description 3
- 239000002577 cryoprotective agent Substances 0.000 abstract description 28
- 229920005862 polyol Polymers 0.000 abstract 1
- 150000003077 polyols Chemical class 0.000 abstract 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 53
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 239000000975 dye Substances 0.000 description 7
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 6
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 6
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- BPKIGYQJPYCAOW-FFJTTWKXSA-I calcium;potassium;disodium;(2s)-2-hydroxypropanoate;dichloride;dihydroxide;hydrate Chemical compound O.[OH-].[OH-].[Na+].[Na+].[Cl-].[Cl-].[K+].[Ca+2].C[C@H](O)C([O-])=O BPKIGYQJPYCAOW-FFJTTWKXSA-I 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- -1 polypropylene Polymers 0.000 description 3
- 229930182566 Gentamicin Natural products 0.000 description 2
- 239000012981 Hank's balanced salt solution Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 238000004166 bioassay Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 229960002518 gentamicin Drugs 0.000 description 2
- 238000007443 liposuction Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000004803 Di-2ethylhexylphthalate Substances 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000008156 Ringer's lactate solution Substances 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- WZSDNEJJUSYNSG-UHFFFAOYSA-N azocan-1-yl-(3,4,5-trimethoxyphenyl)methanone Chemical compound COC1=C(OC)C(OC)=CC(C(=O)N2CCCCCCC2)=C1 WZSDNEJJUSYNSG-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- BJQHLKABXJIVAM-UHFFFAOYSA-N bis(2-ethylhexyl) phthalate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000012611 container material Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000021472 generally recognized as safe Nutrition 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000000644 isotonic solution Substances 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 102220031407 rs398124426 Human genes 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000012808 vapor phase Substances 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0653—Adipocytes; Adipose tissue
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Microbiology (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (22)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811052313.6A CN109673621A (zh) | 2012-06-07 | 2013-06-06 | 用于自体脂肪转移手术的组合物及方法 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261656837P | 2012-06-07 | 2012-06-07 | |
US61/656,837 | 2012-06-07 | ||
PCT/US2013/044621 WO2013184978A2 (en) | 2012-06-07 | 2013-06-06 | Compositions and methods for collecting, washing, cryopreserving, recovering and return of lipoaspirates to physician for autologous adipose transfer procedures |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811052313.6A Division CN109673621A (zh) | 2012-06-07 | 2013-06-06 | 用于自体脂肪转移手术的组合物及方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104487567A true CN104487567A (zh) | 2015-04-01 |
CN104487567B CN104487567B (zh) | 2018-09-25 |
Family
ID=49712857
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811052313.6A Pending CN109673621A (zh) | 2012-06-07 | 2013-06-06 | 用于自体脂肪转移手术的组合物及方法 |
CN201380039198.8A Active CN104487567B (zh) | 2012-06-07 | 2013-06-06 | 用于自体脂肪转移手术的组合物及方法 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811052313.6A Pending CN109673621A (zh) | 2012-06-07 | 2013-06-06 | 用于自体脂肪转移手术的组合物及方法 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20160066563A1 (zh) |
EP (1) | EP2859090A4 (zh) |
CN (2) | CN109673621A (zh) |
HK (1) | HK1211052A1 (zh) |
WO (1) | WO2013184978A2 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107921182A (zh) * | 2015-06-10 | 2018-04-17 | 特拉维夫医学研究、基础设施和卫生服务医疗中心基金会 | 用于分离基质血管部分的机械仪器和方法 |
TWI795367B (zh) * | 2016-09-13 | 2023-03-11 | 日商七七科室股份有限公司 | 冷凍保存容器 |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2919374C (en) | 2013-07-30 | 2019-12-03 | Musculoskeletal Transplant Foundation | Acellular soft tissue-derived matrices and methods for preparing same |
US11083758B2 (en) * | 2014-05-14 | 2021-08-10 | Prime Merger Sub, Llc | Placental membrane preparations and methods of making and using same for regenerating cartilage and spinal intervertebral discs |
US10912864B2 (en) | 2015-07-24 | 2021-02-09 | Musculoskeletal Transplant Foundation | Acellular soft tissue-derived matrices and methods for preparing same |
US11052175B2 (en) | 2015-08-19 | 2021-07-06 | Musculoskeletal Transplant Foundation | Cartilage-derived implants and methods of making and using same |
CN111528218A (zh) * | 2019-12-26 | 2020-08-14 | 上海交通大学医学院附属第九人民医院 | 脂肪组织冻存保护剂 |
CN111418577B (zh) * | 2020-03-25 | 2022-06-24 | 南京三生生物技术股份有限公司 | 一种临床级脂肪组织专用冷冻保存液及其制备、使用方法和应用 |
CN111587877A (zh) * | 2020-06-28 | 2020-08-28 | 上海交通大学医学院附属第九人民医院 | 干细胞冻存保护剂、制备方法及应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009115581A2 (en) * | 2008-03-19 | 2009-09-24 | Cryo-Save Ag | Improved cryopreservation of adipose tissue for the isolation of mesenchymal stem cells |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010036665A1 (en) * | 1999-03-18 | 2001-11-01 | Susan M. Young | Method of preparing cryogenically preserved adherent cell containing plate for tissue culture applications |
US6194137B1 (en) * | 1999-04-13 | 2001-02-27 | Organ Recovery Systems, Inc. | Method of cryopreservation of blood vessels by vitrification |
US7112576B1 (en) * | 1999-12-10 | 2006-09-26 | Regents Of The University Of Minnesota | Compositions and methods for cryopreservation of peripheral blood lymphocytes |
US20030054331A1 (en) * | 2001-09-14 | 2003-03-20 | Stemsource, Inc. | Preservation of non embryonic cells from non hematopoietic tissues |
US20050233403A1 (en) * | 2002-05-01 | 2005-10-20 | Adipogenix, Inc. | Human adipocyte cell populations and methods for identifying modulators of same |
WO2005000241A2 (en) * | 2003-06-23 | 2005-01-06 | Macrochem Corporation | Compositons and methods for topical administration |
US8122923B2 (en) * | 2003-10-30 | 2012-02-28 | Teva Medical Ltd. | Safety drug handling device |
CN101084305B (zh) * | 2004-12-22 | 2011-01-12 | 株式会社大冢制药工场 | 胰岛的分离方法 |
EP1747994A1 (en) * | 2005-07-28 | 2007-01-31 | I.D.M. Immuno-Designed Molecules | Serially linked containers for containing a sterile solution |
CA2635469A1 (en) * | 2005-12-28 | 2007-07-05 | Dabur Pharma Limited | A biocompatible, non-biodegradable, non-toxic polymer useful for nanoparticle pharmaceutical compositions |
US7892724B2 (en) * | 2007-07-12 | 2011-02-22 | Warsaw Orthopedic, Inc | Method for enhancing the viability of mammalian cells, tissues and organs using a solution comprising two low molecular weight PEGs |
CN101939417B (zh) * | 2007-12-04 | 2014-02-05 | 蛋白生物动力私人有限公司 | 祖细胞的保护和它们的分化的调节 |
US20100189338A1 (en) * | 2008-04-09 | 2010-07-29 | Nexcelom Bioscience | Systems and methods for counting cells and biomolecules |
CN102438445B (zh) * | 2009-02-23 | 2014-12-10 | 细胞与组织系统股份有限公司 | 组织的无冰低温贮藏法 |
JP2010248160A (ja) * | 2009-04-20 | 2010-11-04 | National Institute Of Advanced Industrial Science & Technology | 細胞延命効果を有するペプチド |
US20120253317A1 (en) * | 2009-12-18 | 2012-10-04 | Birscet, LLC | Adipose tissue management systems |
-
2013
- 2013-06-06 CN CN201811052313.6A patent/CN109673621A/zh active Pending
- 2013-06-06 CN CN201380039198.8A patent/CN104487567B/zh active Active
- 2013-06-06 US US14/406,203 patent/US20160066563A1/en not_active Abandoned
- 2013-06-06 WO PCT/US2013/044621 patent/WO2013184978A2/en active Application Filing
- 2013-06-06 EP EP13800847.9A patent/EP2859090A4/en not_active Withdrawn
-
2015
- 2015-08-14 HK HK15107858.9A patent/HK1211052A1/zh unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009115581A2 (en) * | 2008-03-19 | 2009-09-24 | Cryo-Save Ag | Improved cryopreservation of adipose tissue for the isolation of mesenchymal stem cells |
Non-Patent Citations (2)
Title |
---|
CUI ET AL: "Cryopreservation of human adipose tissues", 《CRYOBIOLOGY》 * |
SONIA GAUCHER,ET AL: "Viability of cryopreserved human skin allografts:effects of transport media and cryoprotectant", 《CELL TISSUE BANK》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107921182A (zh) * | 2015-06-10 | 2018-04-17 | 特拉维夫医学研究、基础设施和卫生服务医疗中心基金会 | 用于分离基质血管部分的机械仪器和方法 |
CN107921182B (zh) * | 2015-06-10 | 2022-09-02 | 特拉维夫医学研究、基础设施和卫生服务医疗中心基金会 | 用于分离基质血管部分的机械仪器和方法 |
TWI795367B (zh) * | 2016-09-13 | 2023-03-11 | 日商七七科室股份有限公司 | 冷凍保存容器 |
Also Published As
Publication number | Publication date |
---|---|
HK1211052A1 (zh) | 2016-05-13 |
CN104487567B (zh) | 2018-09-25 |
EP2859090A4 (en) | 2015-11-25 |
US20160066563A1 (en) | 2016-03-10 |
WO2013184978A3 (en) | 2014-03-20 |
EP2859090A2 (en) | 2015-04-15 |
WO2013184978A2 (en) | 2013-12-12 |
CN109673621A (zh) | 2019-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104487567A (zh) | 用于收集、洗涤、冷冻保存、回收并且将脂肪抽出物返回给医师进行自体脂肪转移手术的组合物及方法 | |
Devine et al. | The platelet storage lesion | |
US20080254471A1 (en) | Apparatus and Method for Microbial and Forensic Sampling and Manipulation | |
JP6531256B2 (ja) | 臍帯血および末梢血の凍結保存方法および凍結保存用溶液 | |
Sieme et al. | Cryopreservation of semen from domestic livestock | |
Enosawa | Isolation of GMP grade human hepatocytes from remnant liver tissue of living donor liver transplantation | |
Gao et al. | A study of policies and guidelines for collecting, processing, and storing coronavirus disease 2019 patient biospecimens for biobanking and research | |
Khuu et al. | Catastrophic failures of freezing bags for cellular therapy products: description, cause, and consequences | |
US10154664B2 (en) | Systems and methods for the digestion of adipose tissue samples obtained from a client for cryopreservation | |
US20160015024A1 (en) | Method for Preparing Adipose Tissue | |
Bandarenko et al. | Successful in vivo recovery and extended storage of additive solution (AS)‐5 red blood cells after deglycerolization and resuspension in AS‐3 for 15 days with an automated closed system | |
Prell et al. | Motility and fertility evaluation of thawed frozen stallion semen after 24 hours of cooled storage | |
BCSH Blood Transfusion Task Force et al. | Guidelines for the collection, processing and storage of human bone marrow and peripheral stem cells for transplantation | |
Scaradavou et al. | Guidelines for cord blood unit thaw and infusion | |
Miura et al. | Quality evaluation of umbilical cord blood progenitor cells cryopreserved with a small-scale automated liquid nitrogen system | |
Halberstadt et al. | Isolation of human cadaveric pancreatic islets for clinical transplantation | |
Feldman | Practical transfusion medicine for the small animal practitioner | |
Guo et al. | Review of Different Temperatures for Biopreservation | |
Stevenson et al. | Pregnancy outcome after insemination of frozen-thawed bovine semen packaged in two straw sizes: A meta-analysis | |
Lornage et al. | Ovarian tissue vitrification: cortex and whole ovary in sheep | |
US20040138822A1 (en) | Method and system for managing batches of immunocompetent cells collected from human or animal subjects for deferred use, and related therapy methods | |
Screnci et al. | Related cord blood banking for haematopoietic stem cell transplantation | |
Hamilton et al. | Hematopoietic Progenitor Cell Apheresis Processing | |
To et al. | Guidelines for the collection, processing, storage and of administration of hemopoietic stem and progenitor cells for transplantation. Report of the Working Party on Hemopoietic Stem Cell Processing, Hematology Discipline Advisory Committee, the Royal College of Pathologists of Australasia | |
CN202190675U (zh) | 血液肿瘤综合诊断用标本盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1211052 Country of ref document: HK |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20170906 Address after: New jersey, USA Applicant after: American clise telm Co. Address before: American Pennsylvania Applicant before: David Moscatro |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20180115 Address after: Guangdong city of Shenzhen province Qianhai Shenzhen Hong Kong cooperation zone before Bay Road No. 1 building 201 room A Applicant after: Mepco cold storage biological technology (Shenzhen) Co.,Ltd. Address before: New jersey, USA Applicant before: American clise telm Co. |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20180202 Address after: 518000 Liyuan Hotel, No. 1018, Liyuan Hotel, No. 1018, Luohu District Hongling Road, Luohu District, Guangdong Province, 3 layer A Applicant after: BAOXIN ASIA PACIFIC BIOTECHNOLOGY (SHENZHEN) CO.,LTD. Address before: 518052 Guangdong city of Shenzhen province Qianhai Shenzhen Hong Kong cooperation zone before Bay Road No. 1 building 201 room A Applicant before: Mepco cold storage biological technology (Shenzhen) Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: Second floor, phase I, comprehensive Xinxing, No.1, Haihong Road, Fubao community, Fubao street, Futian District, Shenzhen City, Guangdong Province Patentee after: Baoxin Asia Pacific Biotechnology (Shenzhen) Co.,Ltd. Address before: 518000 Liyuan Hotel, No. 1018, Liyuan Hotel, No. 1018, Luohu District Hongling Road, Luohu District, Guangdong Province, 3 layer A Patentee before: Baoxin Asia Pacific Biotechnology (Shenzhen) Co.,Ltd. |
|
PP01 | Preservation of patent right | ||
PP01 | Preservation of patent right |
Effective date of registration: 20201225 Granted publication date: 20180925 |
|
PD01 | Discharge of preservation of patent | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20220802 Granted publication date: 20180925 |